Proyectos
Project PR_EX_2022-36
HUMANIZED-PDX MODELS TO DEVELOP IL-8/CXCR AND CD137 TARGETING THERAPIES TO OVERCOME RESISTANCE TO IMMUNE CHECKPOINT INHIBITORS IN SKIN AND KIDNEY CANCER PATIENTS
edit_calendar
Duration: from 30 June 2023 to 29 June 2028
(60 months)
Current
euro
1,250,000.00 EUR
Of National scope.
Call:
2022 FD CRIS CONTRA EL CÁNCER - EXCELENCIA
(CRIS FUNDACIÓN DE INVESTIGACIÓN PARA VENCER EL CÁNCER)
